
Ocular Therapeutix
Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye.
Market cap
$2.1b
Enterprise value
$1.8b
Share price
$12.32 OCUL
Authorizing premium user...